TheraPHIX™,vivoPHIX™, genoPHIX™ and virusPHIX™

RNAssist Blog

Choose a category:

RNAssist is attending the World Vaccine Congress

RNAssist is attending the World Vaccine Congress

Published on: 24/10/2024

Join us at the World Vaccine Congress next week as we showcase our latest breakthrough in mRNA-LNP stability, TheraPHIX™! We’re thrilled that our CEO, Andrew Goldsborough will be speaking on 31st October at 10am in Theatre 6. His talk, *"TheraPHIX™ technology for ambient temperature liquid-stable mRNA-LNP therapeutics and vaccines"* will delve into how we’re reshaping the future of vaccine delivery and therapeutic stability.

Events
Read more
Introducing TheraPHIX™ our thermostabilization breakthrough

Introducing TheraPHIX™ our thermostabilization breakthrough

Published on: 10/10/2024

RNAssist is proud to announce the development of TheraPHIX™, a groundbreaking solution in mRNA vaccine stability. In collaboration with the Centre for Process Innovation (CPI) and with funding from Innovate UK, we have successfully created an ambient temperature liquid-stable mRNA-LNP formulation.

News
Read more
Fixation Before Dissociation Using a Deep Eutectic Solvent Preserves In Vivo States and Phospho-Signaling in Single-Cell Sequencing

Fixation Before Dissociation Using a Deep Eutectic Solvent Preserves In Vivo States and Phospho-Signaling in Single-Cell Sequencing

Published on: 16/08/2024

Single-cell RNA sequencing presents an opportunity to deconstruct cellular networks but is limited by the loss of biological information. In this study, a new method of fixation before dissociation using a deep eutectic solvent (DES) is presented.

Featured Research
Read more
Taking Insect Immunity to the Single-Cell Level

Taking Insect Immunity to the Single-Cell Level

Published on: 16/08/2024

This research paper used the RNAssist’s vivoPHIX™ system to examine the intricacies of insect innate immunity. Sarah Merkling et al., aimed to gain a deeper understanding of the immune responses in insects at the level of specific organs and cell populations, with the goal of improving our overall knowledge of tissue- or cell-specific immune processes across species and facilitating the creation of models for predicting within-host infection dynamics.

Featured Research
Read more


RNAssist technology supports a wide range of life science applications, including tissue fixation and dissociation, single-cell multiomics (scRNA-seq, CITE-seq), and virus inactivation and transport for enhanced diagnostic testing.

Follow us on LinkedIn

© RNAssist | www.RNAssist.com